BFM
QNRX

Boothbay Fund Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Boothbay Fund Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Hold
59,838
– – 0.01% 1475
2025
Q4 		$863K Buy
+59,838
New +$815K 0.01% 862
2025
Q1 		– Sell
-2,306
Closed -$52.5K – 1708
2024
Q4 		$52.5K Buy
+2,306
New +$52.9K ﹤0.01% 1351

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Boothbay Fund Management's QNRX Position: Q1 2026 in Review

Boothbay Fund Management held its Quoin Pharmaceuticals (QNRX) position steady in Q1 2026 at 59,838 shares worth $395K. The position accounts for 0.01% of the portfolio, ranked #1475.

Boothbay Fund Management first reported a position in QNRX in Q4 2024 and has held it in 3 quarters since. The position peaked at $863K in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Boothbay Fund Management held 59,838 shares of Quoin Pharmaceuticals worth $395K as of Q1 2026.
  • Boothbay Fund Management left its Quoin Pharmaceuticals share count unchanged in Q1 2026.
  • Quoin Pharmaceuticals made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1475 holding.
  • Boothbay Fund Management first reported a position in Quoin Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Boothbay Fund Management's Quoin Pharmaceuticals position peaked at $863K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.